Since the FDA began publishing its rejections of drug approval filings in July last year, companies have become more ...
The revised draft guidance from the US Food and Drug Administration (FDA) on drug master files (DMFs) deals with submissions on confidential information about facilities, manufacturing, processing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results